Tocilizumab in patients with severe COVID-19: a retrospective cohort studyGiovanni Guaraldi, Cristina Mussini, Riccardo Fantini et al.|The Lancet Rheumatology|2020Cited by 998
Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumoniaSara De Biasi, Andrea Cossarizza, Marianna Meschiari et al.|Nature Communications|2020Cited by 846
First and second waves among hospitalised patients with COVID-19 with severe pneumonia: a comparison of 28-day mortality over the 1-year pandemic in a tertiary university hospital in ItalyMarianna Meschiari, Cristina Mussini, Alessandro Cozzi‐Lepri et al.|BMJ Open|2022Cited by 28
Better prognosis in females with severe COVID-19 pneumonia: possible role of inflammation as potential mediatorCristina Mussini, Domenico Lo Tartaro, Alessandro Cozzi‐Lepri et al.|Clinical Microbiology and Infection|2021Cited by 22
Development and validation of a prediction model for tocilizumab failure in hospitalized patients with SARS-CoV-2 infectionCristina Mussini, Giovanni Guaraldi, Alessandro Cozzi‐Lepri et al.|PLoS ONE|2021Cited by 12